Approval · Notice of Compliance 16841 · 2015
ALTACE: Notice of Compliance 16841
Issued April 23, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16841
- Date
- April 23, 2015
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
- Therapeutic class
- Angiotensin converting enzyme inhibitor